Drug profile · INN
cyclobenzaprine hydrochloride
CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride (CYCLOBENZAPRINE HYDROCHLORIDE) is a serotonin 2c (5-ht2c) receptor antagonist. Associated with Tonix Pharmaceuticals Holding. Route of administration: oral. Current US regulatory status: approved.
Drug details — cyclobenzaprine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 4
- Data quality
- 0.89
Quick answer
cyclobenzaprine hydrochloride (CYCLOBENZAPRINE HYDROCHLORIDE) is a serotonin 2c (5-ht2c) receptor antagonist. Associated with Tonix Pharmaceuticals Holding. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2c (5-HT2c) receptor antagonist
Primary target: 5-hydroxytryptamine receptor 2A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12383733
Iontophoresis-based patch type medicine absorption device
granted -
US 12304901
Selective ligands for tau aggregates
granted -
US 12156864
Analogs of cyclobenzaprine and amitryptilene
granted -
US 11998516
Methods and compositions for treating depression using cyclobenzaprine
granted -
US 11975161
Drug releasing coatings for balloon catheters
granted -
US 11839594
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 11737991
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 11566032
Radio-protective and chemo-protective substituted thiols
granted -
US 11376404
Drug releasing coatings for medical devices
granted -
US 11026898
Eutectic formulations of cyclobenzaprine hydrochloride
granted -
US 10994055
Drug releasing coatings for medical devices
granted -
US 10946027
Tianeptine oxalate salts and polymorphs
granted -
US 10912932
Drug releasing coatings for balloon catheters
granted -
US 10912931
Drug releasing coatings for balloon catheters
granted -
US 10864175
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 10864176
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 10835719
Drug releasing coatings for medical devices
granted -
US 10736859
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 10485959
Drug releasing coatings for balloon catheters
granted -
US 10485958
Drug releasing coatings for balloon catheters
granted
Frequently asked questions
What is cyclobenzaprine hydrochloride?
cyclobenzaprine hydrochloride (CYCLOBENZAPRINE HYDROCHLORIDE) is a serotonin 2c (5-ht2c) receptor antagonist. Associated with Tonix Pharmaceuticals Holding. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cyclobenzaprine hydrochloride?
CYCLOBENZAPRINE HYDROCHLORIDE is a marketed brand name for cyclobenzaprine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cyclobenzaprine hydrochloride?
cyclobenzaprine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.